New York State Common Retirement Fund Bei Gene, Ltd. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Bei Gene, Ltd. stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,173 shares of BGNE stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,173
Previous 8,569
42.06%
Holding current value
$2.76 Million
Previous $1.92 Million
16.84%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BGNE
# of Institutions
251Shares Held
45.4MCall Options Held
292KPut Options Held
114K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.4 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.46 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.17 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA5.1MShares$1.16 Billion0.74% of portfolio
-
Baillie Gifford & CO3.67MShares$832 Million0.54% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...